NYSE - Delayed Quote
USD
Elevance Health, Inc. (ELV)
413.60
-6.47
(-1.54%)
At close: 4:00:02 PM EST
413.60
0.00
(0.00%)
After hours: 5:05:00 PM EST
Trade ELV on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for ELV
What's happening with ELV?
Powered by Yahoo ScoutElevance Health reported a stronger-than-expected third quarter, raised its 2026 adjusted earnings-per-share guidance to at least $29, and expects at least 12% adjusted EPS growth in 2027. The outlook depends on Medicaid margin recovery, Medicare Advantage profitability, and continued growth at Carelon, while elevated medical costs and membership changes remain key risks.
Powered by Yahoo Scout
- Previous Close
420.07 - Open
421.34 - Bid 400.00 x 12000
- Ask 433.00 x 32000
- Day's Range
406.90 - 424.11 - 52 Week Range
274.84 - 450.69 - Volume
2,104,112 - Avg. Volume
1,163,700 - Market Cap (intraday)
89.697B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
17.56 - EPS (TTM)
23.55 - Earnings Date (est.) Jan 28, 2027
- Forward Dividend & Yield 6.88 (1.64%)
- 1y Target Est
482.38 - Morningstar Rating Rating available with Stock Picks access
Recent News
View More
Performance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
ELV
19.72%
S&P 500 (^GSPC)
10.17%
1-Year Return
ELV
32.98%
S&P 500 (^GSPC)
10.25%
3-Year Return
ELV
3.69%
S&P 500 (^GSPC)
74.66%
5-Year Return
ELV
5.90%
S&P 500 (^GSPC)
62.86%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 10/30/2026
-
Market Cap
91.10B
-
Enterprise Value
111.62B
-
Trailing P/E
17.84
-
Forward P/E
14.02
-
PEG Ratio (current)
16.54
-
Price/Sales (ttm)
0.46
-
Price/Book (mrq)
2.04
-
Enterprise Value/Revenue
0.55
-
Enterprise Value/EBITDA
12.15
Financial Highlights
Profitability and Income Statement
-
Profit Margin
2.55%
-
Return on Assets (ttm)
4.00%
-
Return on Equity (ttm)
11.48%
-
Revenue (ttm)
201.83B
-
Net Income Avi to Common (ttm)
5.14B
-
Diluted EPS (ttm)
23.55
Balance Sheet and Cash Flow
-
Total Cash (mrq)
37.85B
-
Total Debt/Equity (mrq)
68.66%
-
Levered Free Cash Flow (ttm)
7.99B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Elevance Earnings: 2026 Outlook Rises on Better-Than-Expected Margins
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
-
Daily – Vickers Top Buyers & Sellers for 10/26/2026
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
-
Elevance Earnings: 2026 Outlook Rises on Better-Than-Expected Margins
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
-
Medicare Advantage Star Ratings Release Boosts Key MA Insurer's Prospects
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
